149 related articles for article (PubMed ID: 15498877)
21. Activity of quinolones against gram-positive cocci: clinical features.
Giamarellou H
Drugs; 1995; 49 Suppl 2():58-66. PubMed ID: 8549418
[TBL] [Abstract][Full Text] [Related]
22. [Osteoarticular infections: therapeutic proposals of the Paediatric Infectious Diseases Group of the French Society of Paediatrics (GPIP)].
Grimprel E; Lorrot M; Haas H; Pinquier D; Parez N; Ferroni A; Cohen R;
Arch Pediatr; 2008 Oct; 15 Suppl 2():S74-80. PubMed ID: 19000859
[TBL] [Abstract][Full Text] [Related]
23. [In vitro antibiotic susceptibility to fluoroquinolones].
Wong CA; Galvis V; Tello A; Villareal D; Rey JJ
Arch Soc Esp Oftalmol; 2012 Mar; 87(3):72-8. PubMed ID: 22423655
[TBL] [Abstract][Full Text] [Related]
24. Introduction: treatment of Gram-positive infections.
Wise R
J Antimicrob Chemother; 2003 May; 51 Suppl 2():ii5-7. PubMed ID: 12797336
[No Abstract] [Full Text] [Related]
25. [Current value of quinolones in Helicobacter pylori therapy].
Krasz S; Miehlke S; Berning M; Morgner A; Labenz J
Z Gastroenterol; 2011 Aug; 49(8):989-96. PubMed ID: 21811951
[TBL] [Abstract][Full Text] [Related]
26. In vitro activity of tigecycline against gram-positive cocci: a multicentre study in Greece.
Malli E; Spiliopoulou I; Kolonitsiou F; Neocleous Ch; Klapsa D; Pantelidi K; Panopoulou M; Grapsa S; Alepopoulou E; Neonakis I; Alexiou-Daniel S; Bakola D; Koutsia-Carouzou C; Malamou-Lada H; Zerva L; Vlahaki E; Kartali-Ktenidou S; Anastassiou E; Petinaki E
J Antimicrob Chemother; 2008 Nov; 62(5):1158-60. PubMed ID: 18753190
[No Abstract] [Full Text] [Related]
27. Prolonged bacterial exposure to minocycline/rifampicin-impregnated vascular catheters does not affect antimicrobial activity of catheters.
Aslam S; Darouiche RO
J Antimicrob Chemother; 2007 Jul; 60(1):148-51. PubMed ID: 17525051
[TBL] [Abstract][Full Text] [Related]
28. Daptomycin for treatment of patients with bone and joint infections: a systematic review of the clinical evidence.
Falagas ME; Giannopoulou KP; Ntziora F; Papagelopoulos PJ
Int J Antimicrob Agents; 2007 Sep; 30(3):202-9. PubMed ID: 17459668
[TBL] [Abstract][Full Text] [Related]
29. Salvage therapy for complex bone and joint infections with ceftaroline: a multicentre, observational study.
Malandain D; Dinh A; Ferry T; Touchais S; Lustig S; Laurent F; Corvec S; Bémer P; Asseray N; Boutoille D
Int J Antimicrob Agents; 2017 Aug; 50(2):277-280. PubMed ID: 28689872
[No Abstract] [Full Text] [Related]
30. Susceptibility of bacteraemic isolates of gram-positive cocci to daptomycin and other antimicrobial agents.
Amsterdam D; Gorzynski EA; Beam TR; Rotstein C
J Antimicrob Chemother; 1994 May; 33(5):1060-4. PubMed ID: 8089056
[No Abstract] [Full Text] [Related]
31. In vitro studies with DQ-113 and comparison fluoroquinolones to determine propensities to select resistance in gram-positive cocci.
Hong SG; Moland ES; Wickman PA; Black JA; Hossain A; Hanson ND; Thomson KS
Antimicrob Agents Chemother; 2007 Apr; 51(4):1512-4. PubMed ID: 17220419
[TBL] [Abstract][Full Text] [Related]
32. Sensitization of Gram-negative bacteria to rifampin and OAK combinations.
Jammal J; Zaknoon F; Kaneti G; Goldberg K; Mor A
Sci Rep; 2015 Mar; 5():9216. PubMed ID: 25782773
[TBL] [Abstract][Full Text] [Related]
33. [Introduction of Synercid].
Régnier B
Presse Med; 2001 Sep; 30(25 Pt 2):IV. PubMed ID: 11603272
[No Abstract] [Full Text] [Related]
34. Cotrimoxazole-resistant Nocardia sclerokeratitis: effective therapy with fourth-generation fluoroquinolones.
Mittal V; Fernandes M
Can J Ophthalmol; 2012 Dec; 47(6):e58-60. PubMed ID: 23217523
[No Abstract] [Full Text] [Related]
35. Differences in distribution and antimicrobial susceptibility of anaerobes isolated from complicated intra-abdominal infections versus diabetic foot infections.
Claros M; Citron DM; Goldstein EJ; Merriam CV; Tyrrell KL
Diagn Microbiol Infect Dis; 2013 Aug; 76(4):546-8. PubMed ID: 23727512
[TBL] [Abstract][Full Text] [Related]
36. Fourth-generation fluoroquinolones in the treatment of mycobacterial infectious keratitis after laser-assisted in situ keratomileusis surgery.
Lee SB; Oliver KM; Strube YN; Mohan SK; Slomovic AR
Can J Ophthalmol; 2005 Dec; 40(6):750-3. PubMed ID: 16391641
[TBL] [Abstract][Full Text] [Related]
37. Review of third-and fourth-generation fluoroquinolones in ophthalmology: in-vitro and in-vivo efficacy.
Scoper SV
Adv Ther; 2008 Oct; 25(10):979-94. PubMed ID: 18836691
[TBL] [Abstract][Full Text] [Related]
38. Tsukamurella: an emerging opportunistic ocular pathogen.
Almeida DR; Miller D; Alfonso EC
Can J Ophthalmol; 2010 Jun; 45(3):290-3. PubMed ID: 20628423
[No Abstract] [Full Text] [Related]
39. [Peptostreptococcus magnus osteoarticular infections after orthopedic surgery. 14 cases and pathogenicity factors].
Felten A; Desplaces N; Nizard R; Sedel L; Lagrange P
Pathol Biol (Paris); 1998 Jun; 46(6):442-8. PubMed ID: 9769879
[TBL] [Abstract][Full Text] [Related]
40. Chronic bacterial prostatitis and relapsing Enterococcus faecalis bacteraemia successfully treated with moxifloxacin.
van Nieuwkoop C; Visser LG; Groeneveld JH; Kuijper EJ
J Infect; 2008 Feb; 56(2):155-6. PubMed ID: 18083235
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
